End-stage Renal Disease Market Share

Statistics for the 2023 & 2024 End-stage Renal Disease market share, created by Mordor Intelligence™ Industry Reports. End-stage Renal Disease share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of End-stage Renal Disease Industry

The market studied is fragmented due to the presence of many major market players. Market players adopt the strategies, such as organic growth strategies (treatment type launches, treatment type approvals) and others (such as patents and events), which are prioritized by corporations with inorganic growth strategies, like acquisitions, partnerships, and collaborations. Some market players are Nipro Corporation, Fresenius SE & Co. KGaA, Baxter International Inc., Medtronic PLC, B. Braun SE, Asahi Kasei Medical Co. Ltd, Cantel Medical, Nikkiso Co., etc.

End Stage Renal Disease Market Leaders

  1. Nipro Corporation

  2. Fresenius SE & Co. KGaA

  3. Baxter International Inc

  4. Medtronic PLC

  5. B. Braun SE

*Disclaimer: Major Players sorted in no particular order

End-stage Renal Disease Market Concentration

End Stage Renal Disease Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)